[HTML][HTML] Breast cancer brain metastasis: from etiology to state-of-the-art modeling

MK Farahani, M Gharibshahian, A Rezvani… - Journal of Biological …, 2023 - Springer
Currently, breast carcinoma is the most common form of malignancy and the main cause of
cancer mortality in women worldwide. The metastasis of cancer cells from the primary tumor …

[HTML][HTML] Protein kinase targets in breast cancer

M García-Aranda, M Redondo - International journal of molecular …, 2017 - mdpi.com
With 1.67 million new cases and 522,000 deaths in the year 2012, breast cancer is the most
common type of diagnosed malignancy and the second leading cause of cancer death in …

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors

T Robinson, M Pai, J Liu, F Vizeacoumar, T Sun… - Cell Cycle, 2013 - Taylor & Francis
Triple-negative breast cancer (TNBC) represents an aggressive subtype, for which radiation
and chemotherapy are the only options. Here we describe the identification of disulfiram, an …

Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity

AAM Eissa, KFM Aljamal, HS Ibrahim, HA Allam - Bioorganic Chemistry, 2021 - Elsevier
The present study describes the synthesis of three series of 4-substituted pyridopyrimidin
derivatives 4a-h, 5a-d. 6a-d, starting from 2-amino-6-(4-methoxyphenyl)-4-(4-(substituted) …

[HTML][HTML] Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth

Y Bi, J Li, B Ji, N Kang, L Yang, DA Simonetto… - The American journal of …, 2014 - Elsevier
Sphingosine-1-phosphate (S1P) is produced by sphingosine kinase 1 and is implicated in
tumor growth, although the mechanisms remain incompletely understood. Pancreatic …

[HTML][HTML] The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined

L Jin, WR Liu, MX Tian, J Fan, YH Shi - World Journal of Surgical …, 2016 - Springer
Over the past two decades, huge amounts of research were launched to understand the
functions of sphingosine. Many pathways were uncovered that convey the relative functions …

[HTML][HTML] Preclinical models of brain metastases in breast cancer

NN Knier, S Pellizzari, J Zhou, PJ Foster, A Parsyan - Biomedicines, 2022 - mdpi.com
Breast cancer remains a leading cause of mortality among women worldwide. Brain
metastases confer extremely poor prognosis due to a lack of understanding of their specific …

Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells

S Xiao, J Yang - Investigational new drugs, 2019 - Springer
Summary Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite, which
regulates a broad range of physiological and pathophysiological processes. The signaling …

Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule

DS Miller - Journal of Pharmacology and Experimental …, 2014 - ASPET
P-glycoprotein is an ATP-driven xenobiotic export pump that is highly expressed in barrier
and excretory tissues, where it greatly influences drug pharmacokinetics. Recent studies in …

Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology

O Abuhussein, J Yang - Investigational New Drugs, 2020 - Springer
Summary Sphingosine-1-phosphate (S1P) is an important sphingolipid metabolite that
regulates a wide range of physiological and pathophysiological processes. Our previous …